ESSA Pharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Total operating expenses were $21,206,824.

Profit Margin

ESSA Pharma Inc. (NASDAQ:EPIX): Profit margin
2015 0 -8.56M
2016 217 -13.14M -6055299.54%
2017 0 -4.49M
2018 0 -11.63M
2019 0 -10.44M
2020 0 -23.44M
2021 0 -36.80M
2022 0 -35.10M
2023 0 -26.58M
2024 0 0

EPIX Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
000000002170
Cost of revenue
0118.49K121.78K109.46K110.32K0046.14K00
Gross profit
0-118.49K-121.78K-109.46K-110.32K00-46.14K2170
Operating exp.
Research and development
21.20M21.32M24.41M24.25M12.14M6.69M4.87M5.72M13.06M4.38M
Selling and marketing
022.56K00000000
Total operating expenses
21.20M32.13M36.96M37.14M23.52M12.16M10.80M10.86M18.70M9.23M
Operating income
0-32.13M-35.34M-36.90M-23.11M-12.15M-10.80M-11.65M-19.64M-9.31M
Other income (expenses), net
05.55M127.78K68.76K-214.09K1.74M111K11.67M6.65M-107.35K
Income before tax
0-26.58M-35.21M-36.83M-23.73M-10.40M-11.60M-4.38M-12.98M-8.56M
Income tax expense
01.6K-112K-34.34K-289K38K27K116K151K77.76K
Net income
0-26.58M-35.10M-36.80M-23.44M-10.44M-11.63M-4.49M-13.14M-8.56M
Earnings per share
Basic EPS
-0.64-0.6-0.8-0.96-1.04-1.24-2.55-3.09-9.77-9.34
Diluted EPS
-0.64-0.6-0.8-0.96-1.04-1.24-2.55-3.09-9.77-9.34
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source